Cargando…
Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomato...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447372/ https://www.ncbi.nlm.nih.gov/pubmed/28567336 http://dx.doi.org/10.1016/j.eucr.2017.04.011 |
_version_ | 1783239326646140928 |
---|---|
author | Ayati, Mohsen Nowroozi, Mohammad Reza Mortazavi, Afshin Ohadian Moghadam, Solmaz Ghorani, Hossein |
author_facet | Ayati, Mohsen Nowroozi, Mohammad Reza Mortazavi, Afshin Ohadian Moghadam, Solmaz Ghorani, Hossein |
author_sort | Ayati, Mohsen |
collection | PubMed |
description | BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. He was treated successfully with antitubercular therapy and prednisolone. |
format | Online Article Text |
id | pubmed-5447372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-54473722017-05-31 Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer Ayati, Mohsen Nowroozi, Mohammad Reza Mortazavi, Afshin Ohadian Moghadam, Solmaz Ghorani, Hossein Urol Case Rep Oncology BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. He was treated successfully with antitubercular therapy and prednisolone. Elsevier 2017-05-25 /pmc/articles/PMC5447372/ /pubmed/28567336 http://dx.doi.org/10.1016/j.eucr.2017.04.011 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Oncology Ayati, Mohsen Nowroozi, Mohammad Reza Mortazavi, Afshin Ohadian Moghadam, Solmaz Ghorani, Hossein Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer |
title | Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer |
title_full | Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer |
title_fullStr | Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer |
title_full_unstemmed | Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer |
title_short | Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer |
title_sort | management of hepatic granulomatous tuberculosis after bcg therapy for bladder cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447372/ https://www.ncbi.nlm.nih.gov/pubmed/28567336 http://dx.doi.org/10.1016/j.eucr.2017.04.011 |
work_keys_str_mv | AT ayatimohsen managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer AT nowroozimohammadreza managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer AT mortazaviafshin managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer AT ohadianmoghadamsolmaz managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer AT ghoranihossein managementofhepaticgranulomatoustuberculosisafterbcgtherapyforbladdercancer |